Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany – results of a database analysis from May 2010 to April 2012

Abstract

BackgroundSeasonal influenza is one of the most significant infectious diseases in Germany; epidemic outbreaks occur every winter and cause substantial morbidity and mortality. However, published data from Germany on the current economic burden of influenza and the costs per episode are lacking.MethodsA retrospective database analysis was conducted using a longitudinal electronic medical records database (IMS Disease Analyzer). Patients with influenza, diagnosed by German office-based physicians using ICD-10 J09-11 (International Classification of Diseases, 10th revision), who were observable in the database from 12 months before the index (diagnosis) date until 1 month afterwards, were included. The selection window, defined to cover two influenza seasons, was May 2010 to April 2012. Direct and indirect costs were evaluated from payer, patient and societal perspectives. Published unit costs and tariffs from Germany (2012) were used for the analysis.ResultsA total of 21,039 influenza-attributable episodes in 17,836 adults, managed by primary care physicians (PCP) and 7,107 episodes in 6,288 children, managed by pediatricians, were eligible for analysis. The mean (±Standard Deviation (SD)) age of the adults with at least one episode was 46 (±18) years and 7 (±4) years in the children. The presence of clinical risk factors was documented for 39 % episodes in adults and 24 % episodes in children, with the most common being cardiovascular diseases in adults (29 %) and chronic respiratory diseases in children (23 %). Complications and severe symptoms accompanied the influenza-attributable episode (adults: 37 %, children: 54 %), bronchitis (adults: 16 %, children: 19 %) and acute upper respiratory infection (adults: 15 %, children: 21 %) being the most frequent. From a societal perspective, the total average mean cost (±SD) per episode was €514 (±609) in adults, where work days lost were the main cost driver (82 %), and €105 (±224) in children. Complications and severe symptoms increased the cost per episode versus episodes without by 1.7 times in adults (€684 (±713) vs. €413 (±510)) and nearly 3 times in children (€149 (±278) vs. €55 (±116)).ConclusionsBased on a large patient sample derived from representative PCP and pediatricians panels, our results demonstrate that seasonal influenza is associated with substantial clinical and economic burden in Germany.Electronic supplementary materialThe online version of this article (doi:10.1186/s12889-015-1885-0) contains supplementary material, which is available to authorized users.

Protective Effect of Seasonal Influenza Vaccination in Elderly Individuals with Disability in Taiwan: A Propensity Score–Matched, Nationwide, Population-Based Cohort Study

“…To our knowledge, the present study is the first population-based study to demonstrate that the protective effect of influenza vaccine in reducing all-cause mortality, influenza-related hospitalization, LOS, and medical expenditure in elderly individuals with disability. Medical expenditure of individuals with influenza, including those with influenza-related complications such as pneumonia [24], respiratory diseases [25], respiratory failure [26,27], heart disease [28][29][30], hemorrhagic stroke [31], and ischemic stroke [30], has often led to higher spending. In our study, we found that influenza vaccination was associated with reductions in all-cause mortality, influenza-related hospitalization, LOS, and medical costs decreased among elderly individuals with a disability (Tables 1 and 2).…”

Long-lasting cough in an adult German population: incidence, symptoms, and related pathogens

“…However, probably because of the long-lasting symptoms, 63% of patients received antibiotics, 47% antitussives, and 17% steroids. A retrospective database analysis of drug prescriptions in influenza and influenza-like illnesses of much shorter duration of coughing in Germany [17] showed that in that cohort, around 50% of patients did not receive prescriptions. However, among those who did receive drugs, 40% received antibiotics (63% in our study) and 12% received antitussives (37% in our study).…”

Evaluation of an ICD-10-based electronic surveillance of acute respiratory infections (SEEDARI) in Germany

“…Die betroffenen Altersgruppen, die Gesamtzahl der Erkrankungen und auch deren Schwere können in verschiedenen Jahren stark variieren. Je nach zirkulierendem Virustyp und Zeitdauer der erhöhten Viruszirkulation kommt es zu mehr als 20.000 bis 30.000 geschätzten Influenza-bedingten Hospitalisierungen, einer auf Bevölke-rungsebene messbaren Übersterblichkeit und erheblichen direkten und indirekten Kosten für das Gesundheitswesen und die Volkswirtschaft [2,3]. Eine zeitnahe Surveillance ist daher wichtig zur Beurteilung der Situation und für die Anpassung von Präventionsmaßnah-men.…”